Facilitating high quality research that will inform the identification of effective new treatment
We have sites located across sites in Greater Manchester, offering capabilities in PET, MR and PET-MR imaging, to facilitate high quality research that will inform the identification of effective new treatments and the targeted use of treatment for greatest patient benefit.
Our flagship building, the Wolfson Molecular Imaging Centre, co-located by the Christie NHS Foundation Trust houses our radiochemistry facility. Equipped with a cyclotron, GMP cleanroom, laboratories and QC capabilities, we have an ambitious radiotracer development programme and manufacture radiotracers for a range of research studies and external organisations. We hold manufacturing licences (specials and IMP) from the Medicines Healthcare Products Regulatory Agency (MHRA).
We also offer pre-clinical PET imaging opportunities at WMIC and our lab on the main University campus.
Training and education
Colleagues in the Faculty of Biology, Medicine and Health contribute to a taught Masters programme in Medical Imaging Science.
We also welcome PhD students in the Faculty and offer a PhD/DPhil programme in Biomedical Imaging Sciences.
Many of our PhD students are based at WMIC, with its PET and MR imaging capabilities at close hand.
We are involved in a wide range of research activities; here’s a snapshot:
EPSRC/CRUK Cancer Imaging Centre
The PI for the project is Prof Alan Jackson
MRC – Dementias Platform UK initiative (DPUK)
The scanner is housed in the Nuclear Medicine department at St Mary’s Hospital in Manchester and is available for research scanning now. This is an exciting development for the University’s Imaging Facilities, as it is one of just seven PET-MR scanners in the UK – and the only one in the North-West.
MRC/NIHR – Deep and Frequent Phenotyping Study (DPUK)
The PI for this study is Dr Iracema Leroi
MRC DPUK MR-PET Harmonisation study
MRC STRATA - Schizophrenia: Treatment Resistance and Therapeutic Advances
EPSRC Quantification of vascular and neuronal pathology in dementia using PET and MRI
MRC Characterisation of the inflammatory component of carotid plaques using PET-CT and PET-MR to develop non-invasive prognostic imaging markers for stroke
The PI for this study is Prof Ian Bruce.
MRC CCHIRAL (Advanced Characterisation of tumour hypoxia using PET-MR to personalise radiotherapy for cervical cancer patients)
The PI for this study is Dr Ananya Choudhury.